Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D R Mishell

Contraception

Showing results (21-30 of 64) with videos related to

Pageof 7
Sort By:
Contraception|March 11, 1975
Termination of early gestation with intramuscular (15S)-15 methyl prostaglandin F2 alphaP F Brenner, M E Lumkin, C Ballard, et al.
Contraception|July 13, 2001
Serum beta-human chorionic gonadotropin levels and endometrial thickness after medical abortionB Harwood, K R Meckstroth, D R Mishell, et al.
Contraception|May 30, 2001
Early pregnancy termination with vaginal misoprostol combined with loperamide and acetaminophen prophylaxisJ K Jain, B Harwood, K R Meckstroth, et al.
Contraception|August 1, 1983
Methods to determine success of attempts to terminate early gestation pregnancies with prostaglandin vaginal suppositoriesP F Brenner, R P Marrs, S Roy, et al.
Contraception|June 1, 1980
Clinical and endocrinologic study of continuous levonorgestrel administration from subcutaneous solid polydimethylsiloxane rodsS Roy, F Stanczyk, D R Mishell, et al.
Contraception|August 1, 1980
Termination of early gestation with a single vaginal suppository of (15S)-15-methyl-prostaglandin F2alpha methyl esterS Roy, P F Brenner, R P Marrs, et al.
Contraception|May 1, 1986
Pregnancy termination with a high and medium dosage regimen of RU 486D Shoupe, D R Mishell, P F Brenner, et al.
Contraception|March 15, 2000
A comparison of tamoxifen and misoprostol to misoprostol alone for early pregnancy terminationJ K Jain, K R Meckstroth, M Park, et al.
Contraception|December 1, 1981
Termination of early gestation with (15S)-15-methyl prostaglandin F2 alpha methyl ester vaginal suppositoriesR P Marrs, P F Brenner, S Roy, et al.
Contraception|July 1, 1980
Serum levels of ethinylestradiol following its ingestion alone or in oral contraceptive formulationsP F Brenner, U Goebelsmann, F Z Stanczyk, et al.
Pageof 7

Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
Contraception|March 11, 1975
Termination of early gestation with intramuscular (15S)-15 methyl prostaglandin F2 alphaP F Brenner, M E Lumkin, C Ballard, et al.
Contraception|July 13, 2001
Serum beta-human chorionic gonadotropin levels and endometrial thickness after medical abortionB Harwood, K R Meckstroth, D R Mishell, et al.
Contraception|May 30, 2001
Early pregnancy termination with vaginal misoprostol combined with loperamide and acetaminophen prophylaxisJ K Jain, B Harwood, K R Meckstroth, et al.
Contraception|August 1, 1983
Methods to determine success of attempts to terminate early gestation pregnancies with prostaglandin vaginal suppositoriesP F Brenner, R P Marrs, S Roy, et al.
Contraception|June 1, 1980
Clinical and endocrinologic study of continuous levonorgestrel administration from subcutaneous solid polydimethylsiloxane rodsS Roy, F Stanczyk, D R Mishell, et al.
Contraception|August 1, 1980
Termination of early gestation with a single vaginal suppository of (15S)-15-methyl-prostaglandin F2alpha methyl esterS Roy, P F Brenner, R P Marrs, et al.
Contraception|May 1, 1986
Pregnancy termination with a high and medium dosage regimen of RU 486D Shoupe, D R Mishell, P F Brenner, et al.
Contraception|March 15, 2000
A comparison of tamoxifen and misoprostol to misoprostol alone for early pregnancy terminationJ K Jain, K R Meckstroth, M Park, et al.
Contraception|December 1, 1981
Termination of early gestation with (15S)-15-methyl prostaglandin F2 alpha methyl ester vaginal suppositoriesR P Marrs, P F Brenner, S Roy, et al.
Contraception|July 1, 1980
Serum levels of ethinylestradiol following its ingestion alone or in oral contraceptive formulationsP F Brenner, U Goebelsmann, F Z Stanczyk, et al.
Pageof 7